Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
8.51
+0.98 (13.01%)
At close: Dec 3, 2025, 4:00 PM EST
8.35
-0.16 (-1.88%)
After-hours: Dec 3, 2025, 5:01 PM EST

Vor Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
174138153437433-
Upgrade
Market Cap Growth
181.88%-9.38%-65.05%0.75%--
Upgrade
Enterprise Value
210829341225-
Upgrade
Last Close Price
7.5322.2045.00133.00232.40-
Upgrade
PB Ratio
-1.431.011.742.00-
Upgrade
P/TBV Ratio
-1.431.011.742.00-
Upgrade
Debt / Equity Ratio
0.000.330.240.160.080.38
Upgrade
Quick Ratio
9.054.948.8117.5520.434.76
Upgrade
Current Ratio
9.165.199.0418.0621.124.81
Upgrade
Return on Equity (ROE)
--94.52%-58.74%-39.45%-52.09%-155.02%
Upgrade
Return on Assets (ROA)
-144.27%-44.42%-31.67%-21.55%-27.09%-63.23%
Upgrade
Return on Capital (ROIC)
--48.11%-33.10%-22.29%-28.68%-73.05%
Upgrade
Return on Capital Employed (ROCE)
-214.30%-97.50%-69.00%-32.60%-29.70%-66.00%
Upgrade
Earnings Yield
-1444.21%-84.57%-77.25%-21.09%-15.90%-
Upgrade
FCF Yield
-85.30%-72.25%-66.44%-21.44%-16.86%-
Upgrade
Buyback Yield / Dilution
-66.44%-2.25%-69.88%-18.30%-15547.86%-
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q